Immix Biopharma, Inc.IMMXNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank60
3Y CAGR+157.3%
5Y CAGR-59.6%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+157.3%/yr
Annual compound
5Y CAGR
-59.6%/yr
Recent acceleration
Percentile
P60
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.05 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 0.00 | -100.0% |
| 2020 | 7.60 | +74.7% |
| 2019 | 4.35 | - |